SGI Targets Bioscience Market With Hybrid System That Blends x86 Cluster, SMP, FPGAs | GenomeWeb
SGI has emerged from a major reorganization with a renewed focus on its core scientific and technical markets, including the life sciences, according to Deepak Thakkar, the firm’s bioscience segment marketing manager.
The company, which filed for bankruptcy protection last May and emerged from Chapter 11 status in October, has a new management team that “has charged us with developing solutions for specific industry segments so that we can address the needs of specific groups of customers,” Thakkar said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.